Form 4 for IDXX Idexx Laboratories
Accepted 2021-08-05 00:00:00 ET · period of report 2021-08-03 · accession 0001567619-21-014513 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-05 | 2021-08-03+ | IDXX | TWIGGE GIOVANI | SVP | M - OptEx | $168.92 | +20.5K | 28.5K | +253% | +$3.45M |
| DM | 2021-08-05 | 2021-08-03+ | IDXX | TWIGGE GIOVANI | SVP | S - Sale+OE | $698.25 | -20.3K | 17.1K | -54% | -$14.17M |
| DM | 2021-08-05 | 2021-08-03+ | IDXX | TWIGGE GIOVANI | SVP | M - OptEx | — | -20.5K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-03 | M | A | 1,476 | $67.85 | 18,447.48 | D | — | — | (F1) Includes a total of 21.4780 shares of common stock acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021 and June 30, 2021. |
| 2 | Common | Common Stock | 2021-08-03 | M | A | 8,874 | $141.60 | 27,321.48 | D | — | — | |
| 3 | Common | Common Stock | 2021-08-03 | S | D | 7,036 | $695.34 | 20,285.48 | D | — | — | (F2) Represents the weighted average price of the shares sold ranging from a low of $695.00 to a high of $695.995 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 4 | Common | Common Stock | 2021-08-03 | S | D | 1,838 | $696.32 | 18,447.48 | D | — | — | (F3) Represents the weighted average price of the shares sold ranging from a low of $696.02 to a high of $696.78 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 5 | Common | Common Stock | 2021-08-04 | M | A | 5,141 | $178.26 | 23,588.48 | D | — | — | |
| 6 | Common | Common Stock | 2021-08-04 | M | A | 3,068 | $206.94 | 26,656.48 | D | — | — | |
| 7 | Common | Common Stock | 2021-08-04 | M | A | 1,893 | $288.78 | 28,549.48 | D | — | — | |
| 8 | Common | Common Stock | 2021-08-04 | S | D | 1,319 | $700.00 | 27,230.48 | D | — | — | |
| 9 | Common | Common Stock | 2021-08-04 | S | D | 9,242 | $700.30 | 17,988.48 | D | — | — | (F4) Represents the weighted average price of the shares sold ranging from a low of $700.00 to a high of $700.995 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 10 | Common | Common Stock | 2021-08-04 | S | D | 860 | $701.36 | 17,128.48 | D | — | — | (F5) Represents the weighted average price of the shares sold ranging from a low of $701.05 to a high of $701.91 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 11 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2021-08-04 | M | D | 3,068 | — | 4,118 | D | $206.94 · — to 2029-02-13 | 3,068 Common Stock | (F11) Not applicable. (F9) Grant of option to buy 7,186 shares of Issuer common stock that vest in four annual installments beginning February 14, 2020. |
| 12 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2021-08-04 | M | D | 1,893 | — | 5,677 | D | $288.78 · — to 2030-02-13 | 1,893 Common Stock | (F11) Not applicable. (F10) Grant of option to buy 7,570 shares of Issuer common stock that vest in four annual installments beginning February 14, 2021. |
| 13 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2021-08-04 | M | D | 5,141 | — | 2,866 | D | $178.26 · — to 2028-02-13 | 5,141 Common Stock | (F11) Not applicable. (F8) Grant of option to buy 8,007 shares of Issuer common stock that vest in five annual installments beginning February 14, 2019. |
| 14 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2021-08-03 | M | D | 8,874 | — | 1,512 | D | $141.60 · — to 2027-02-13 | 8,874 Common Stock | (F11) Not applicable. (F7) Grant of option to buy 10,386 shares of Issuer common stock that vest in five annual installments beginning February 14, 2018. |
| 15 | Derivative | Incentive Stock Option (right-to-buy) | 2021-08-03 | M | D | 1,476 | — | 0 | D | $67.85 · — to 2026-02-13 | 1,476 Common Stock | (F11) Not applicable. (F6) Grant of option to buy 1,476 shares of Issuer common stock that vested as to 1 share on February 14, 2017, February 14, 2018 and February 14, 2020, respectively, and as to the remainder on February 14, 2021. |